BioCentury
ARTICLE | Company News

Finch, Takeda deal

April 7, 2017 8:02 PM UTC

Finch granted Takeda exclusive, worldwide rights to develop and commercialize FIN-524 and follow-on products to treat inflammatory bowel disease (IBD). Finch will receive $10 million up front and is e...

BCIQ Company Profiles

Takeda Pharmaceutical Co. Ltd.